← Back to Clinical Trials
Recruiting NCT04377854

NCT04377854 Prognostic Value of BNP in MCS - a 25 Year Follow up Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04377854
Status Recruiting
Phase
Sponsor Rigshospitalet, Denmark
Condition Heart Failure
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2020-09-18
Primary Completion 2045-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Observation. No intervention per se.2) Observation and collection and of blood sample

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2020-09-18 with a primary completion date of 2045-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy. Patients will be followed up for 25 years after inclusion.

Eligibility Criteria

Inclusion Criteria: * All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark * Age\>18 years Exclusion Criteria: * No consent

Contact & Investigator

Central Contact

Kiran Mirza, MD

✉ KiranMirza@dadlnet.dk

📞 +4535451442

Frequently Asked Questions

Who can join the NCT04377854 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04377854 currently recruiting?

Yes, NCT04377854 is actively recruiting participants. Contact the research team at KiranMirza@dadlnet.dk for enrollment information.

Where is the NCT04377854 trial being conducted?

This trial is being conducted at Copenhagen, Denmark.

Who is sponsoring the NCT04377854 clinical trial?

NCT04377854 is sponsored by Rigshospitalet, Denmark. The trial plans to enroll 1,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology